Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
artemisia asiatica extract
- Development stage
- Unknown
- Lead developer
- Addpharma
- Administration
- Oral
01
Overview
AD-2341 is a pharmaceutical candidate developed by **Addpharma** (a subsidiary of **Yuhan Corporation**) for the treatment of **gastritis**. It is a specific formulation of **artemisia asiatica extract**, a botanical drug derived from the *Artemisia asiatica* plant. The extract contains active flavonoids such as eupatilin and jaceosidin, which provide gastroprotective effects by stimulating the synthesis of endogenous **prostaglandins**, increasing gastric mucus secretion, and scavenging free radicals. AD-2341 has been primarily studied as a component of **AD-234**, a fixed-dose combination (FDC) therapy that pairs artemisia asiatica extract with the cytoprotective agent **rebamipide**. This combination aims to provide synergistic protection of the gastric mucosa and improve symptoms in patients with acute or chronic gastritis.
- Brand names
- Stillen 2XStillen2XStillen-2X
- Other names
- DA-9601DA9601DA 9601
02
Targets
ALOX12 (Arachidonate 12-lipoxygenase, 12S type)
Beyond the preview
Go deeper on artemisia asiatica extract.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on artemisia asiatica extract.